Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDK2 | Q15119 | 17/20 | 0.38 |
| ▸ | PGR | P06401 | 1/20 | 0.33 |
| ▸ | KMO | O15229 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17273403 | 0.89 | KMO (0.42) | PDK2KMO | |
| SCHEMBL17280875 | 0.89 | KMO (0.42) | PDK2KMO | |
| SCHEMBL17273276 | 0.89 | KMO (0.42) | PDK2KMO | |
| SCHEMBL17280872 | 0.88 | PDK2 (0.41) | PDK2PGRKMO | |
| SCHEMBL17280878 | 0.87 | PDK2 (0.34) | PDK2KMO | |
| SCHEMBL25533606 | 0.86 | ENPP3 (0.38) | PDK2 | |
| SCHEMBL25533584 | 0.85 | ALDH1A1 (0.39) | PDK2 | |
| SCHEMBL25533613 | 0.84 | ALDH1A1 (0.39) | PDK2 | |
| SCHEMBL25533624 | 0.84 | MEN1 (0.40) | PDK2 | |
| SCHEMBL25533675 | 0.84 | MEN1 (0.41) | PDK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210013421-A1 | Heterocyclic Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2021-01-14 | — | — | US | disclosed |
| US-20180198073-A1 | Heterocyclic Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2018-07-12 | — | — | US | disclosed |
| US-9923149-B2 | Heterocyclic compound, light-emitting element, light-emitting device, electronic device, and lighting device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2018-03-20 | — | — | US | disclosed |
| US-9923149-B2 | Heterocyclic compound, light-emitting element, light-emitting device, electronic device, and lighting device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2018-03-20 | — | — | US | disclosed |
| US-20150340622-A1 | Heterocyclic Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2015-11-26 | — | — | US | disclosed |
| US-20150340622-A1 | Heterocyclic Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2015-11-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150340622-A1 | Heterocyclic Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device | CRY1, GNA11, CYP1A1 | PDK2 1856/4885PGR 1840/4885KMO 2424/4885 |
| US-20210013421-A1 | Heterocyclic Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device | CRY1, GNA11, CYP1A1 | PDK2 1856/4885PGR 1840/4885KMO 2424/4885 |
| US-20180198073-A1 | Heterocyclic Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device | CRY1, GNA11, CYP1A1 | PDK2 1856/4885PGR 1840/4885KMO 2424/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.